XML 21 R8.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Preferred Stock
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Treasury Stock
Accumulated Other Comprehensive Loss
Beginning balance at Dec. 31, 2021 $ 3,600 $ (43)   $ 4 $ 8,531 $ (100) $ 464 $ 57 $ (5,273) $ (126)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net Income/(Loss) 1,736           1,736      
Other comprehensive income/(loss) 8                 8
Share repurchases (187)               (187)  
Equity-based awards activity, net [1] 2       2          
Common stock dividends and dividend equivalents declared [2] (86)           (86)      
Ending balance at Mar. 31, 2022 5,030     4 8,433   2,171   (5,460) (118)
Beginning balance at Dec. 31, 2021 3,600 $ (43)   4 8,531 $ (100) 464 $ 57 (5,273) (126)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net Income/(Loss) 2,249                  
Other comprehensive income/(loss) 6                  
Ending balance at Jun. 30, 2022 5,300     4 8,442   2,600   (5,626) (120)
Beginning balance at Mar. 31, 2022 5,030     4 8,433   2,171   (5,460) (118)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net Income/(Loss) 513           513      
Other comprehensive income/(loss) (2)                 (2)
Shares reissuance for ESPP 3       1       2  
Share repurchases (168)               (168)  
Equity-based awards activity, net 8       8          
Common stock dividends and dividend equivalents declared [2] (84)           (84)      
Ending balance at Jun. 30, 2022 5,300     4 8,442   2,600   (5,626) (120)
Beginning balance at Dec. 31, 2022 3,828   $ 0 4 8,457   1,408   (5,864) (177)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net Income/(Loss) (1,335)           (1,335)      
Issuance of Series A Preferred Stock 636   650   (14)          
Other comprehensive income/(loss) 1                 1
Equity-based awards activity, net [1] 38       38          
Common stock dividends and dividend equivalents declared [2] (88)           (88)      
Ending balance at Mar. 31, 2023 3,080   650 4 8,481   (15)   (5,864) (176)
Beginning balance at Dec. 31, 2022 3,828   0 4 8,457   1,408   (5,864) (177)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net Income/(Loss) (1,027)                  
Other comprehensive income/(loss) 7                  
Ending balance at Jun. 30, 2023 3,332   650 4 8,504   205   (5,861) (170)
Beginning balance at Mar. 31, 2023 3,080   650 4 8,481   (15)   (5,864) (176)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net Income/(Loss) 308           308      
Other comprehensive income/(loss) 6                 6
Shares reissuance for ESPP 4       1       3  
Equity-based awards activity, net [1] 23       23          
Common stock dividends and dividend equivalents declared [2] (88)           (88)      
Ending balance at Jun. 30, 2023 $ 3,332   $ 650 $ 4 $ 8,504   $ 205   $ (5,861) $ (170)
[1] Includes $(8) million, $(8) million and $(6) million of equivalent shares purchased in lieu of tax withholding on equity compensation issuances for the quarters ended March 31, 2023, June 30, 2023 and March 31, 2022, respectively
[2] Dividends per common share were $0.3775 for the quarters ended June 30 and March 31, 2023 and $0.35 for the quarters ended June 30 and March 31, 2022